Acute-phase reactant serum amyloid A (A-SAA) is used in clinical laboratories as an indicator of inflammation and is more conclusive than the detection of CRP in patients with viral infections, and severe acute pancreatitis (Ye et al., 2020; Zhu et al., 2021). Here, CRP is linked to viral infectious disease.